Cite
HARVARD Citation
De Carlo, E. et al. (2021). Brigatinib as a treatment of ALK-positive non-small cell lung cancer. Expert review of precision medicine and drug development. 6 (5), pp. 299-305. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
De Carlo, E. et al. (2021). Brigatinib as a treatment of ALK-positive non-small cell lung cancer. Expert review of precision medicine and drug development. 6 (5), pp. 299-305. [Online].